Keyphrases
Antiretroviral Therapy
39%
Sub-Saharan Africa
26%
Malawi
24%
People Living with HIV (PLHIV)
22%
Dapivirine Vaginal Ring
20%
HIV Patients
19%
Confidence Interval
16%
South Africa
12%
HIV Prevention
11%
Kenya
10%
HIV-1 Prevention
10%
Preterm Birth
9%
HIV Infection
8%
Dapivirine
8%
AIDS/HIV
8%
Randomized Trial
8%
Sexual Behavior
8%
Human Immunodeficiency Virus Type 1 (HIV-1)
8%
African Women
8%
Pregnant Women
7%
Tenofovir
7%
Breastfeeding Women
7%
Men Who Have Sex with Men
7%
Trial Network
7%
Phase II Trial
7%
National Population-based Survey
6%
Intimate Partner Violence
6%
Tuberculosis Incidence
6%
Open-label Extension
6%
Women of Reproductive Age
6%
PEPFAR
6%
Systemic Inflammation
6%
HIV Research Network
6%
Adjusted Odds Ratio
6%
Herpes Simplex Virus 2 (HSV-2)
6%
Pre-exposure Prophylaxis (PrEP)
5%
Uganda
5%
Zimbabwe
5%
Low Birth Weight
5%
AIDS Indicator Survey
5%
Menses
5%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
5%
Gestational Age
5%
Randomized Clinical Trial
5%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Prevalence
21%
Antiretroviral Therapy
18%
Vagina Ring
17%
Dapivirine
17%
Human Immunodeficiency Virus Infection
15%
Men Who Have Sex with Men
13%
Pre-Exposure Prophylaxis
8%
Tenofovir
8%
Randomized Clinical Trial
8%
Premature Labor
8%
Prospective Cohort Study
7%
Odds Ratio
5%
Low and Middle Income Countries
5%
Menstruation
5%
Cohort Effect
5%
Placebo
5%
Cross Sectional Study
5%